Glucosylated Epigallocatechin Gallate (EGCG) Derivatives Combined With EGFR Tyrosine Kinase Inhibitor Overcome Resistance in EGFR T790M Mutant Lung Cancer
Biomedical Journal of Scientific & Technical Research
doi 10.26717/bjstr.2019.18.003133
Full Text
Open PDFAbstract
Available in full text
Date
May 24, 2019
Authors
Publisher
Biomedical Research Network, LLC